Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Value of Plasma Ribavirin Assay During the Combination Therapy " Pegylated Interferon + Ribavirin " in Chronic Hepatitis C.

NCT00209755 is registered in ClinicalTrials.gov with Hopital A Michallon as lead sponsor.

NCT NCT00209755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Value of Plasma Ribavirin Assay During the Combination Therapy " Pegylated Interferon + Ribavirin " in Chronic Hepatitis C.
Lead sponsor
Hopital A Michallon
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2003
Completion date
July 31, 2004
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c